Establishes the rare disease advisory council to identify best practices, raise awareness regarding rare diseases, evaluate barriers to access to care, and to make recommendations to the legislature and the governor.
S 2400 creates a workgroup to study blood clots and pulmonary embolisms in the state. The workgroup, appointed by the governor and legislative leaders, will include healthcare providers, patients, family members, and advocates. It must study annual incidence rates, current data collection methods, patient impacts, care standards, emerging treatments, and develop a risk surveillance system. The workgroup will issue policy recommendations within one year to improve patient awareness, surveillance in healthcare facilities (like hospitals), and written risk notices for patients. These recommendations will be published by the health department after submission.
Requires hospitals to have a registered professional nurse as a sitting and voting member of the governing entity responsible for developing a hospital's strategic plan, structure, systems, policies and programs.
Strengthens protections for patients regarding sexual misconduct by medical providers; requires medical expert consultants involved in investigations disclose conflicts of interest and to not be under investigation, on warning, or on probation; requires a zero-tolerance policy to be adopted and training to be provided on sexual misconduct by the board for professional misconduct; includes provisions related to the right to have a chaperone; includes sexual misconduct in the definition of professional misconduct.
Requires that general hospitals that provide mastectomy surgery, lymph node dissection or lumpectomy provide information to such patients concerning options for breast reconstruction.
Provides that the commissioner of education may promulgate rules and regulations for a health education curriculum to include menstrual disorders, including but not limited to, endometriosis.
Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Requires that services at addiction treatment centers operated by the office of addiction services and supports shall not be refused at such centers if a person is unable to pay.
Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.